Among the OSCC locations, floor of the mouth tumors were more likely to CD4- and tumors of the tongue were more likely to express higher levels of T cell markers (especially CD3 and CD4) compared to the other oral cavity subsites. This evidence concerns the gene CD4 and tongue neoplasm.